Gap26 inhibitor treatment in cellular TMJOA model

Exploratory Score: 0.900 Price: $0.50 Temporomandibular joint osteoarthritis H₂O₂-treated chondrocytes with Gap26 inhibitor Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting Cx43 in H₂O₂-treated chondrocytes with Gap26 inhibitor. Primary outcome: Reduced hemichannel opening and suppressed Wnt signaling

Description

A pharmacological intervention study using Gap26, a specific Connexin 43 inhibitor, to investigate the functional role of Cx43 in chondrocyte responses to oxidative stress. The study examined whether blocking Cx43 hemichannel function could prevent or reduce oxidative stress-induced degenerative changes, Wnt/β-catenin signaling activation, and extracellular matrix degradation in the cellular model of TMJOA.

TARGET GENE
Cx43
MODEL SYSTEM
H₂O₂-treated chondrocytes with Gap26 inhibitor
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
Wnt/β-catenin signaling
SOURCE
extracted_from_pmid_41757775
PRIMARY OUTCOME
Reduced hemichannel opening and suppressed Wnt signaling

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.900 composite

Protocol

Treatment of chondrocytes with Gap26 inhibitor followed by H₂O₂-induced oxidative stress, assessment of hemichannel function, Wnt/β-catenin signaling, and degenerative markers

Expected Outcomes

Gap26 would reduce hemichannel opening, suppress Wnt signaling, and mitigate degenerative changes

Success Criteria

Demonstration of reduced hemichannel activity, decreased Wnt/β-catenin signaling, and protection against degenerative changes

Related Hypotheses (1)

Context-Dependent Cx43 Modulation Based on Disease Stage0.724

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.